|1.||Bi, Feng: 5 articles (07/2011 - 01/2004)|
|2.||Wang, Wei: 5 articles (06/2011 - 09/2003)|
|3.||Li, Lei: 4 articles (04/2015 - 07/2005)|
|4.||Wen, Ji-Fang: 4 articles (12/2011 - 06/2004)|
|5.||Li, Jing-He: 4 articles (12/2011 - 06/2004)|
|6.||Lin, Jing: 4 articles (10/2005 - 10/2003)|
|7.||Zhu, Zhi: 4 articles (10/2005 - 10/2003)|
|8.||Zhang, X: 4 articles (11/2000 - 01/2000)|
|9.||Zhao, Guo-qiang: 3 articles (06/2012 - 11/2007)|
|10.||Pu, Peiyu: 3 articles (05/2012 - 01/2006)|
07/08/2011 - "In this study, we evaluated the transfection efficiency (percentage of transfected cells) and therapeutic potential (potency of IGF-1R knockdown) of liposomal magnetofection of plasmids expressing GFP and shRNAs targeting IGF-1R (pGFPshIGF-1Rs) in A549 cells and in tumor-bearing mice as compared to lipofection using Lipofectamine 2000. "
07/07/2014 - "PPG1 supermolecules showed significantly superior transfection efficiencies compared to either PEI 25K or Lipofectamine 2000 in most cell lines tested including normal cells (HEK293A) and cancer cells (Bel7402, HepG2, and HeLa). "
10/01/2012 - "Then the HL-60 cell vaccine expressing the protein onto the cell surface was prepared by lipofectamine transfection and its anti-tumor effect and mechanism were further studied. "
07/01/2011 - "Prostate PC-3 tumor cells were transfected with a plasmid containing either mdm2 small interfering (Si-mdm2) or the WT p53 gene (Pp53) alone, or both (Pmp53), using Lipofectamine in vitro and attenuated Salmonella enterica serovar Typhi vaccine strain Ty21a (Salmonella Typhi Ty21a) in vivo. "
06/01/2011 - "In vitro: A plasmid expressing the BNIP3 gene was transfected into human cervical cancer HeLa cells using Lipofectamine(2000), and western blot and immunohistochemistry analysis were performed to evaluate the expression of BNIP3 in transfected cells. "
01/01/2011 - "The optimized gene transfection efficacy of L3 was nearly 5.5 times more efficient than that of the popular commercially available gene delivery agent Lipofectamine 2000™ in human lung carcinoma cells A549. "
09/01/2013 - "PcDNA3.0-FDT-AIFδ1-480 was transfected into human breast carcinoma MCF-7 cells with lipofectamine. "
12/01/2011 - "Human gastric carcinoma MKN45 cells were stably transfected with Twist antisense plasmid using the lipofectamine transfection technique. "
09/14/2010 - "Then pCL-neo-PTEN-siLivinp, pCL-neo-PTEN, pRNAT-U6.1-Livin, pCL-neo and pRNAT-U6.1 were respectively transfected into the gastric carcinoma cell line (BGC823) with LipofectAMINE(TM) 2000. "
08/01/2010 - "PinX1 and PinX1siRNA eukaryotic expression vectors were constructed by recombinant technology and transfected into gastric carcinoma cells using Lipofectamine 2000. "
|3.||Prostatic Neoplasms (Prostate Cancer)
08/01/2014 - "Then it was transfected into PC-3M human prostate cancer cells by Lipofectamine (TM) 2000. "
08/29/2006 - "Human prostate cancer cells of the line LNCaP were cultured and transfected by the recombinant plasmid pcDNA3.1(-)-HIF-1alpha containing the gene HIF1alpha with Lipofectamine 2000 system. "
04/07/2015 - "Fluorescence microscopy showed that a fluorescein-tagged Pt-TFO localizes in both the cytoplasm and nucleus when it is transfected into LAPC-4 cells, a human prostate cancer cell line, using Lipofectamine 2000. "
05/01/2011 - "A lipofectamine preparation of the Zn(2+)-DNA complex displayed enhanced cytotoxicity toward prostate cancer cells relative to the individual components prepared as lipofectamine complexes indicating the potential utility of Zn(2+)-DNA complexes for cancer treatment."
10/01/2004 - "Metafectene is superior to lipofectamine in the transfection of G(s) alpha prostate cancer cells."
|4.||Hepatocellular Carcinoma (Hepatoma)
11/01/2015 - "Besides, Lipofectamine 2000 was employed to transfect the eukaryotic expression vector pcDNA3.1-WIF1 and blank plasmid pcDNA3.1 into hepatocellular carcinoma cell lines. "
10/21/2005 - "Plasmid pCMVp53 was transfected or cotransfected with pCMVHBVa (wild-type HBV) or PCMVHBVb (mutation type HBV) into the hepatoma cell line SMMU-7721 by lipofectamine. "
04/07/2005 - "Recombinant sense and antisense p33(ING1b) plasmids were transfected into hepatoma cell line HepG2 with lipofectamine. "
09/01/2004 - "The hNIS gene was transfected to human hepatocellular carcinoma SK-Hep1 cell lines using lipofectamine plus reagent. "
07/01/2004 - "Plasmid pCMVp53 was transfected or cotransfected with pCMVHBVa (wild type HBV) or PCMVHBVb (mutant type HBV) into the hepatoma cell line SMMC-7721 by lipofectamine. "
|5.||Breast Neoplasms (Breast Cancer)
08/01/2007 - "Highly metastatic human breast cancer cell line MDA-MB-231 was transfected with pCMV-KAI1 or mock transfected plasmid pCMV with lipofectamine. "
07/01/2007 - "The vector was transfected into human breast cancer cell Bcap37 by Lipofectamine 2000, and the expression of (His)(6)-eIF3s4 fusion protein was detected by Western blot. "
10/01/2006 - "pERE-NIS was transferred to MCF-7, human breast cancer cells, which highly expressed oestrogen receptor-alpha with lipofectamine. "
02/01/2006 - "An eukaryotic expression vector containing 1.6 kb of human entire coding sequence of ER beta (pCDNA3-ER beta) was transfected into human breast cancer MCF-7 cells using lipofectamine 2000. "
04/01/2005 - "Human breast cancer cell line MDA468 was transfected with pcDNA3.1-PTEN or mock transfected plasmid pcDNA3.1(-) with lipofectamine. "
|1.||Indicators and Reagents (Reagents)
|3.||Gs GTP-Binding Protein alpha Subunits (G(s)alpha)
|6.||Small Interfering RNA (siRNA)
|9.||DNA (Deoxyribonucleic Acid)
|10.||antibiotic G 418